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Abnormal lipid metabolism has been linked to age-related macular degeneration (AMD); choroidal neo-
vascularization in late AMD commonly causes blindness. Sene et al. (2013) now demonstrate that in aged
macrophages decreased ABCA1 expression, regulated by liver X receptor and miR-33, impairs export of
intracellular cholesterol, which promotes neovascular AMD.Age-related macular degeneration (AMD)
is a leading cause of blindness. Subretinal
drusen, yellow or white lipid-laden de-
posits comprising esterified cholesterol
and ApoB-containing lipoproteins, are an
early hallmark of AMD (Curcio et al.,
2010). In dry AMD, drusen formation can
progress to geographic atrophy with ulti-
mate degeneration of the light-sensing
photoreceptor cells in themacula. Howev-
er, in 10% of patients, AMD progresses
to the ‘‘wet’’ form with choroidal neovas-
cularization (CNV), often resulting in rapid
and severe central vision loss (Figure 1A).
In addition to aging, epidemiologic and
genetic studies have identified AMD risk
factors in lipidmetabolism, including com-
mon risk factors for atherosclerosis and
immunity/inflammation (Fritsche et al.,
2013; Klein et al., 2005). Previous studies
have focused on the chemotaxis and dru-
sen-derived activation of inflammatory
cells in AMD (Combadie`re et al., 2007;
Doyle et al., 2012). Although lipid-rich dru-
sen are associated with macrophages,
the link between lipid dysregulation and
proangiogenic cell activation in neovascu-
lar AMD is not well understood. Macro-
phages in different tissue environments
may exhibit two different phenotypes: M1
and M2. While classic M1 macrophages
are proinflammatory and induce TNF-a,
IL-6, and IL-1b, the alternatively activated
M2 macrophages expressing IL-10 and
TGF-b are anti-inflammatory and proan-
giogenic. In this issue, Sene et al. demon-
strate that, in aging macrophages,
impaired cholesterol efflux due to miR-
33-dependent ABCA1 downregulation in-
duces polarization to a proangiogenic M2
form to promote CNV (Sene et al., 2013).Sene et al. show that macrophages iso-
lated from aging mice and humans have
reduced levels of the cholesterol trans-
porter ABCA1 and, in mice, higher levels
of intracellular cholesterol and oxidized
cholesterol metabolites (Sene et al.,
2013). In conditional knockout mice,
depletion of ABCA1 specifically in macro-
phages results in increased cholesterol
retention in macrophages and, impor-
tantly, significantly increases neovascula-
rization in laser-induced CNV, an animal
model for neovascular AMD. Interestingly,
increaseddietary intakeof cholesterolwith
a high-fat diet in mice is also associated
with the same phenotypic ‘‘aging’’
changes in macrophages and also with
increased laser-inducedCNV.Theauthors
then demonstrate that cholesterol content
in macrophages regulates CNV by pro-
moting macrophage polarization into a
proangiogenic M2 phenotype. They show
that ABCA1 levels may be mediated by
both liver X receptor (LXR) and miR-33.
Importantly, either activation of LXR with
a synthetic agonist or inhibition of miR-33
with LNA miR-33 inhibitor can protect
against laser-induced CNV (Figure 1B).
While this study establishes the impor-
tance of macrophage cholesterol content
in inducing CNV, an issue that remains to
be addressed is how intracellular choles-
terol dictates their polarization and activa-
tion state from an M1 to an M2 phenotype
to induce angiogenesis. Recent studies in
AMDshowan important role for inflamma-
somes, intracellular protein complexes
activated by extracellular or endocyto-
sized particles (Doyle et al., 2012; Tarallo
et al., 2012). Perhaps activation of inflam-
masomes by intracellular cholesterol mayCell Metabolismcontribute to macrophage polarization.
Another question emerging from the
present study is how aging macrophages
acquire the senescent phenotype, since
the average macrophage life span is less
than 20 days. Do they inherit senescence
information from the progenitor cells, or
are newly formed macrophages rapidly
turned into a senescent phenotype in
response to an aged retinal environment
with increased oxidative stress? The au-
thors suggest that in aging macrophages,
ABCA1 expression may be mediated by
increased levels of miR-33. miR-33 is a
microRNA embedded within the gene
encoding sterol-regulatory element-bind-
ing factor-2 (SREBF-2), a transcriptional
regulator of cholesterol synthesis.
Recently, miR-33 was found to regulate
cholesterol efflux through ABCA1 and
ABCG1 and high-density lipoprotein
(HDL) biogenesis (Rayner et al., 2010). It
is interesting that Dicer1, a miRNA pro-
cessing enzyme, is also implicated in
inducing Alu RNA toxicity in retinal
pigment epithelial cells (RPE) in AMD (Tar-
allo et al., 2012). This may suggest that
defective RNA processing in aging cells,
possibly in both RPE and macrophages,
may contribute to senescence.
Together, the findings from this paper
suggest cholesterol metabolism, and spe-
cifically ABCA1 and its regulators LXR and
miR-33, as new therapeutic targets for
treating neovascular AMD. Current treat-
ment of wet AMD focuses on anti-VEGF
therapy, which successfully suppresses
CNV. However, therapies that prevent
CNV would be desirable. The idea of tar-
geting cholesterol transporter ABCA1 is
consistent with ABCA1 being genetically17, April 2, 2013 ª2013 Elsevier Inc. 471
Figure 1. ABCA1-Mediated Cholesterol Efflux Influences Choroidal Neovascularization
(A) A schematic drawing of a human eye illustrates cholesterol containing drusen (yellow spots) and choroidal neovascularization (CNV) in the macula.
(B) Aging induces increased levels of miR-33, leading to decreased expression of cholesterol transporter ABCA1. Lack of ABCA1 results in impaired cholesterol
efflux frommacrophages, leading to alternative activation of macrophages from the classic M1 phenotype to the proangiogenic M2 phenotype, and thereby pro-
motes laser-induced CNV formation. Activation of liver X receptor (LXR), a nuclear transcription factor, and inhibition of miR-33 both lead to increased ABCA1 and
protection against CNV.
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Previewslinked to AMD risk (Chen et al., 2010).
ABCA1 expression can be directly en-
hanced by LXR, a transcription factor and
also a nuclear receptor for oxidized
cholesterol. However, many other genes
involved in lipid metabolism such as
apolipoprotein E and lipoprotein lipase
are also direct transcriptional targets of
LXR. Whether the effect of LXR activation
is mediated exclusively through ABCA1
may be elucidated using an LXR agonist
in ABCA1-deficient mice. Alternatively, in-
hibition of miR-33 may offer a novel and
appealing approach to treat neovascular
AMD, considering that inhibition of miR-
33 was recently found to promote regres-
sion of atherosclerosis and normalization
of dyslipidemias in animal models. It is
interesting that statins inhibiting HMG-
CoA reductase and cholesterol synthesis
arewidely used to lower serumcholesterol
to reduce cardiovascular disease risk.
Though AMD and atherosclerosis share
common risk factors, clinical studies have
failed to conclusively link statin use with
reduced AMD risk (Peponis et al., 2010).
This new study suggests that modulating
intracellular cholesterol levels in macro-
phages via targeting ABCA1, LXR, and
miR-33 may be more important than
lowering systemic serum levels in AMD.
While this paper shows convincing data
on macrophage cholesterol homeostasis
in CNV formation in wet AMD, the implica-472 Cell Metabolism 17, April 2, 2013 ª2013tion of these findings in dry AMD, themore
common form without CNV, is less clear.
It is unknown if influencing macrophage
activation may help prevent drusen
accumulation and photoreceptor degen-
eration. Do the cholesterol-laden macro-
phages contribute to drusen formation
when they die, or are they simply unable
to phagocytose lipid components to pre-
vent cholesterol/lipid buildup in drusen?
Is ABCA1-dependent cholesterol trans-
port in photoreceptors and RPE as impor-
tant for CNV and drusen formation?
Answering these questions will require
further research.
Collectively, Sene et al. clearly demon-
strate that cholesterol homeostasis via
ABCA1 in aging macrophages is impor-
tant for CNV. Proving this is true in
humans in neovascular AMD requires
further investigation, as the inflammatory
response in mice and human may be
very different. However, this new study
brings us closer to understanding impor-
tant cellular lipid metabolism regulation
inmacrophages underlying the pathogen-
esis of CNV and suggests therapeutic
potential in targeting cholesterol traf-
ficking in inflammatory cells in AMD.
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